Home / Ibritumomab Tiuxetan (90Y) / Canada
CA ATC V10XX02 · updated 2 Nov 2026
Ibritumomab Tiuxetan (90Y) shortage in Canada
Is there an Ibritumomab Tiuxetan (90Y) shortage in Canada?
Yes. As of 2 Nov 2026, 1 Ibritumomab Tiuxetan (90Y) product is reported short in Canada, the first since 1 Dec 2020. No return date has been given. Main reason: manufacturing problem.
Also short in Italy. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ZEVALIN (Kit for preparation of 90Y-Ibritumomab Tiuxetan) | SERVIER CANADA INC | 1 Dec 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.